Role of Contrast-Enhanced Spectral Mammography in the detection of breast cancer

Objective : to assess the benefits of using contrast-enhancer spectral mammography in patients with an established category BI-RADS 4a, 4b according results a standard examination (digital and ultrasound). Materials methods . The date 425 suspicious period from 2018 2021 were analyzed. As part additional examination, all underwent contrast-enhanced follow by histological verification identified changes. sensitivity specificity evaluated. Results final diagnosis breast cancer was 247 (58.1%) out women. Multicenter multifocal growth diagnosed 17 (6.8%) 247, primary multiple synchronous detected 6 (2.4%) 247. False-positive cases when assessing CESM mainly consisted of: typical atypical ductal hyperplasia, fibroadenoma, intraductal papilloma. Conclusion Contrast-enhancer is highly sensitive specific method detection malignant tumors breast. also allows minimizing number unwanted interventions categories.